Recognition of the amyloid precursor protein by human γ-secretase
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
The machinery behind amyloid peptides: β-Amyloid peptides, which are derived from amyloid precursor protein (APP), form the plaques in the brain that are characteristic of Alzheimer's disease. Zhou et al. report a high-resolution structure of a transmembrane segment of APP bound to human γ-secretase, the transmembrane protease that cleaves APP to give β-amyloid peptides (see the Perspective by Lichtenthaler and Güner). Disease-associated mutations within presenilin-1, the catalytic subunit of APP, likely affect how the substrate is bound and thus which peptides are generated, with some being more amyloidogenic. It may now be possible to exploit the features of substrate binding to design inhibitors. Science , this issue p. eaaw0930 ; see also p. 690
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, the 6H8 (61) fragment, obtained through NMR screening from the Maybridge library, may act as a covalent warhead targeting the pathological substrate APP of γ-secretase, thereby hindering Aβ production.569,570”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [570]
In the citing paper
“The alteration of an interaction between APP and PSEN1 has also been demonstrated for other APP mutations within the transmembrane domain close to the γ-secretase processing sites by cryoEM [186], and is associated with increased production of C83/C99 (CTFs) and an increased Aβ42/Aβ40 ratio [187].”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [186]
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571 · cited 1×
“The atomic model was manually improved using COOT (53).”
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E., Armache, J.-P., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,777
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“Of these, Ab42 and Ab43 are particularly prone to aggregation and formation of amyloid plaques (3, 10, 11).”
BackgroundRELION: Implementation of a Bayesian approach to cryo-EM structure determination
Scheres, S. H. W. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.09.006 · Cited by 5,446
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 1×
“The type I transmembrane (TM) protein APP is first cleaved by a- or b-secretase to generate a transmembrane fragment of 83 or 99 residues (APP-C83 or APPC99), respectively (4, 5) (fig.”
BackgroundThe Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
Kopan, R., & Ilagan, M. X. G. (2009) · Cell · doi:10.1016/j.cell.2009.03.045 · Cited by 3,643
Cited by
Items 301–328 of 328
Trambauer, J. (2020) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.26870
Comparison of Different Transmembrane Substrates of Intramembrane Proteases by NMR Spectroscopy
Guschtschin-Schmidt, N. (2024) · Repository KITopen (Karlsruhe Institute of Technology) · doi:10.5445/ir/1000172595
dos Santos Guilherme, M. (2023) · Gutenberg Open Science · doi:10.25358/openscience-8972
Characterization of Gamma-Secretase-Mediated Cleavage of Receptor Tyrosine Kinases
Merilahti, J. A. M. (2021) · UTUPub (University of Turku)
The Dynamic Personality of the Amyloid Precursor Protein’s Transmembrane Domain
Götz, A., Langosch, D., & München, T. U. (2022) · mediaTUM (Technical University of Munich)
Investigating neural differentiation capacity in Alzheimer’s disease iPSC-derived neural stem cells
Burrows, A. (2023) · e-space (Manchester Metropolitan University)
The Role of INPP5D in Microglial Function and Amyloid Pathogenesis
Lin, P. B. (2023) · IUScholarWorks (Indiana University) · doi:10.7912/yxj0-rn10
Gutiérrez Fernández, S. (2025) · Lirias
Villegas-Llerena, C., Paredes-Moscosso, S. R., Guevara, M. L., Obispo, D., Custodio, N., Montesinos, R., Parodi, J. F., Flores-Flores, O., Hardy, J., & Fujita, R. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1724380
Mutations Alter Conformations and Dynamics of APP‐TMDs: An RDC Analysis
Krause, F., Moser, C., Elsing, D., Silber, M., Hoffmann, F., Woordes, Y. T., Luy, B., & Muhle‐Goll, C. (2026) · ChemistryEurope · doi:10.1002/ceur.202500336
Valverde, A. (2020) · theses.fr (ABES) · doi:10.70675/f1b70734zf4e3z4870z8fbdz950d831642a7
Recent Advances in the Development of γ-Secretase Modulators to Treat Alzheimer’s Disease
Johnson, D. S., Pettersson, M., Liu, C., Mekala, S., & Li, Y. (2026) · Topics in medicinal chemistry · doi:10.1007/7355_2026_187
Balaan, C., Patwardhan, G. Y., Sachs, R. K., Kumasaka, H., Sadagopan, S., Aou, S., Lee, A. J., Nelson, L. T., Hew, B. E., Owens, J. B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.14.717551
Rana, D., Das, S., & Mazumder, A. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.32s.74
Membrane Protein Insertion in Cells: Principles, Pathways, and Quality Control
Peled‐Zehavi, H., Yemini, R., & Fluman, N. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.5c01033
Dai, L., Lv, S., Guo, H., Li, Z., Li, J., Wang, Y., Du, M., Wu, D., Ma, K., Wu, N., et al. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-026-01656-9
Fujii, S., Takahashi‐Iwata, I., Matsushima, M., Yaguchi, H., Takatsuka, A., Hara, N., Ikeuchi, T., & Yabe, I. (2026) · Internal Medicine · doi:10.2169/internalmedicine.7327-26
Sajjad, A., Mei, J., Wang, C., Jia, M., Nouman, M. F., & Ai, H. (2026) · Langmuir · doi:10.1021/acs.langmuir.6c00533
Ramarajan, R., Kumar, H. S. S., Sreepathi, D., Kumar, M., Gollapalli, P., Gnanasekaran, T. S., & Gurushankara, H. P. (2026) · Scientific Reports · doi:10.1038/s41598-026-57647-3
Clemente, W. S., Bezerra, K. S., Matias, E. G. C., Oliveira, J. I. N., & Fulco, U. L. (2026) · Physical Chemistry Chemical Physics · doi:10.1039/d6cp02037b
Intramembrane proteolysis: principles of substrate recognition and membrane protein fate
Avci, D., Steigleder, S. S., & Lemberg, M. K. (2026) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2026.09.005
Poonam, Rana, R., Thakur, M., Sharma, A., Pannu, S., Sharma, S., Naman, S., Rani, S., Devi, D., Kumar, V., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1908830
Потенциал гамма-секретазы как мишени для лечения болезни Альцгеймера
Георгиевич, С. П., Михайлович, М. И., Сергеевич, К. Е., Попова, А. О., Сергеевна, Ч. А., Юнкер, Е. А., Александрович, М. А., & Витальевна, С. О. (2026) · Scientific Notes of V I Vernadsky Crimean Federal University Biology Chemistry
BindingDB (2023) · UC San Diego · doi:10.7270/q2hd80pd
BindingDB Entry 50011224: Generation of Leads for γ-Secretase Modulation.
BindingDB (2021) · UC San Diego · doi:10.7270/q2x06bnx
BindingDB (2022) · UC San Diego · doi:10.7270/q2v69p6t
Ma, S., Duan, L., Dong, H., Ma, X., Guo, X., Liu, J., Li, G., Yu, Y., Xu, Y., Yuan, G., et al. (2021) · doi:10.3389/fonc.2021.717917.s001
Self-citation
Metadata
- Authors
- Zhou, R., Yang, G., Guo, X., Zhou, Q., Lei, J., & Shi, Y.
- Affiliations
- Center for Life Sciences (CN)
- Westlake University (CN)
- Corresponding author
- Zhou, Rui
- Yang, Guanghui
- Shi, Yigong
- Venue
- Science
- Published
- 2019-02-15
- Volume
- 363
- Issue
- 6428
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4231640017
- Cited by
- 304
- References
- 55
- Citations by year
- 2026: 22 · 2025: 26 · 2024: 39 · 2023: 38 · 2022: 45 · 2021: 48 · 2020: 52 · 2019: 34
- FWCI
- 31.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- Funders
- National Natural Science Foundation of China (31621092)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid precursor protein, gamma-secretase, beta-amyloid peptide, Alzheimer's disease, presenilin 1, substrate recognition, protein complex structure, disease-associated mutations, substrate binding, gamma-secretase inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.